Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
143.08
+4.29 (3.09%)
At close: May 12, 2025, 4:00 PM
143.08
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
CRL Revenue
Charles River Laboratories International had revenue of $984.17M in the quarter ending March 29, 2025, a decrease of -2.71%. This brings the company's revenue in the last twelve months to $4.02B, down -2.16% year-over-year. In the year 2024, Charles River Laboratories International had annual revenue of $4.05B, down -1.92%.
Revenue (ttm)
$4.02B
Revenue Growth
-2.16%
P/S Ratio
1.82
Revenue / Employee
$200,129
Employees
20,100
Market Cap
7.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 28, 2024 | 4.05B | -79.42M | -1.92% |
Dec 30, 2023 | 4.13B | 153.35M | 3.86% |
Dec 31, 2022 | 3.98B | 435.90M | 12.31% |
Dec 25, 2021 | 3.54B | 616.23M | 21.08% |
Dec 26, 2020 | 2.92B | 302.71M | 11.55% |
Dec 28, 2019 | Pro | Pro | Pro |
Dec 29, 2018 | Pro | Pro | Pro |
Dec 30, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 26, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CRL News
- 2 days ago - Activist Elliott reaches key agreement with Charles River. Here are three ways to create value - CNBC
- 5 days ago - S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments - Investopedia
- 5 days ago - Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization - Benzinga
- 5 days ago - Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help. - Barrons
- 5 days ago - Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More - Investopedia
- 5 days ago - Charles River to add new directors, review business in agreement with Elliott - Reuters
- 5 days ago - Charles River Laboratories Announces First-Quarter 2025 Results - Business Wire